SCHEMBL8550402

SCHEMBL8550402

Cc1cc2c(cc1OC(=O)C(=O)Oc1cc3c(cc1C)CCN(C)C3C1(c3ccsc3)CC1)C(C1(c3ccsc3)CC1)N(C)CC2

nearest known ligand 0.34

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KCNA3 P22001 3/20 0.34
DRD2 P14416 3/20 0.34
DRD1 P21728 3/20 0.34
KMT2A Q03164 2/20 0.33
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32
KDM4E B2RXH2 1/20 0.31
DRD4 P21917 1/20 0.31
MAOA P21397 2/20 0.31
BCHE P06276 1/20 0.31
ACHE P22303 1/20 0.31
MEN1 O00255 1/20 0.31
LMNA P02545 1/20 0.30
TP53 P04637 1/20 0.30
TRPV1 Q8NER1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7411687 0.88 MAOA (0.40) DRD2DRD1KMT2AKDM4EDRD4
SCHEMBL7416842 0.83 DRD1 (0.40) DRD2DRD1DRD4MAOA
Oxalic Acid SCHEMBL7414373 0.83 DRD1 (0.37) DRD2DRD1SLC6A2SLC6A4MAOA
Hydrochloric Acid SCHEMBL7422696 0.83 DRD2 (0.39) DRD2DRD1DRD4MAOA
Bromide SCHEMBL8543859 0.83 DRD2 (0.39) DRD2DRD1KDM4EDRD4MAOA
SCHEMBL8971978 0.72 DRD1 (0.41) DRD2DRD1DRD4
SCHEMBL8549052 0.71 ALDH1A1 (0.35) DRD2DRD1KMT2AKDM4EMEN1
SCHEMBL7417594 0.70 MAOA (0.41) DRD2DRD1KMT2AKDM4EDRD4
SCHEMBL8747354 0.70 TRPV1 (0.48) DRD2DRD1KMT2AKDM4EMAOA
SCHEMBL8747278 0.69 POLB (0.39) KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5807868-A ANALGESICS; PSYCHOLOGICAL DISORDES; PARKINSON*S DIESASE;COGNITION ACTIVATORS; DRUG DEPENDENCE; DYSKINESIA KNOLL AKTIENGESELLSCHAFT (DE) 1998-09-15 US disclosed
US-5804586-A ANALGESICS, PSYCHOLOGICAL DISORDERS KNOLL AKTIENGESELLSCHAFT (DE) 1998-09-08 US disclosed
EP-0707570-B1 ISOQUINOLINE DERIVATIVES AS THERAPEUTIC AGENTS KNOLL AG (DE) 1998-05-06 EP disclosed